These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19243972)

  • 1. Risk assessment and cost-effectiveness/utility analysis.
    Busch M; Walderhaug M; Custer B; Allain JP; Reddy R; McDonough B
    Biologicals; 2009 Apr; 37(2):78-87. PubMed ID: 19243972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we do another test? Decision making in blood banking.
    Hanson M
    Clin Lab Med; 1996 Dec; 16(4):883-93. PubMed ID: 8974200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening the service continuum between transfusion providers and suppliers: enhancing the blood services network.
    Sime SL
    Transfusion; 2005 Oct; 45(4 Suppl):206S-23S. PubMed ID: 16181404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis: what it really means for transfusion medicine decision making.
    Custer B; Hoch JS
    Transfus Med Rev; 2009 Jan; 23(1):1-12. PubMed ID: 19056030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model.
    Custer B; Agapova M; Martinez RH
    Transfusion; 2010 Nov; 50(11):2461-73. PubMed ID: 20497512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing evidence and public opinion in health technology assessments: the case of leukoreduction.
    Cleemput I; Leys M; Ramaekers D; Bonneux L
    Int J Technol Assess Health Care; 2006; 22(4):403-7. PubMed ID: 16984672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion medicine in Norway: new problems and new opportunities.
    Flesland O; Seghatchian J
    Transfus Apher Sci; 2006 Oct; 35(2):93-5. PubMed ID: 17030150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing replacement donors in Sub-Saharan Africa: challenges and affordability.
    Bates I; Manyasi G; Medina Lara A
    Transfus Med; 2007 Dec; 17(6):434-42. PubMed ID: 18067647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion safety: Where are we today?
    Luban NL
    Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streamlined analysis for evaluating the use of preharvest interventions intended to prevent Escherichia coli O157:H7 illness in humans.
    Withee J; Williams M; Disney T; Schlosser W; Bauer N; Ebel E
    Foodborne Pathog Dis; 2009 Sep; 6(7):817-25. PubMed ID: 19737060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood safety in Sub-Saharan Africa: a multi-factorial problem.
    Tagny CT; Mbanya D; Tapko JB; Lefrère JJ
    Transfusion; 2008 Jun; 48(6):1256-61. PubMed ID: 18713111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effective of a small transfusion service laboratory.
    Davis JW; Perone PJ
    MLO Med Lab Obs; 1996 Oct; 28(10):62, 64. PubMed ID: 10161887
    [No Abstract]   [Full Text] [Related]  

  • 13. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.
    Brooks JP
    Transfusion; 2005 Oct; 45(4 Suppl):159S-71S. PubMed ID: 16181401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health policy decisions on medical innovations: what role can early economic evaluation play?
    Hartz S; John J
    Health Policy; 2009 Feb; 89(2):184-92. PubMed ID: 18619704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial impact of work process redesign: experiences of four transfusion services.
    South SF
    Clin Leadersh Manag Rev; 2001; 15(1):30-3. PubMed ID: 11236193
    [No Abstract]   [Full Text] [Related]  

  • 16. Current assessment of risk-benefit by regulators: is it time to introduce decision analyses?
    Hughes DA; Bayoumi AM; Pirmohamed M
    Clin Pharmacol Ther; 2007 Aug; 82(2):123-7. PubMed ID: 17632534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical blood order equation in femoral fracture surgery.
    Kajja I; Bimenya GS; Eindhoven GB; ten Duis HJ; Sibinga CT
    Transfus Med; 2011 Feb; 21(1):7-12. PubMed ID: 20735760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of transfusion related risks: is risk communication to non-experts at all possible?
    Hossenlopp C
    Dev Biol (Basel); 2007; 127():249-58. PubMed ID: 17486898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economics and outcomes methods in risk-based decision-making for blood safety.
    Custer B; Janssen MP;
    Transfusion; 2015 Aug; 55(8):2039-47. PubMed ID: 25855475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenge of an increasingly expensive blood system.
    Wilson K; Hébert PC
    CMAJ; 2003 Apr; 168(9):1149-50. PubMed ID: 12719320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.